002793 罗欣药业
午间休市 11-19 11:30:00
资讯
新帖
简况
罗欣药业最新公告：控股子公司山东罗欣拟公开挂牌出售乐康制药100%股权
证券之星 · 11-18 20:40
罗欣药业最新公告：控股子公司山东罗欣拟公开挂牌出售乐康制药100%股权
盘活资产 罗欣药业(002793.SZ)控股子公司拟公开挂牌出售乐康制药100%股权
智通财经 · 11-18 19:13
盘活资产 罗欣药业(002793.SZ)控股子公司拟公开挂牌出售乐康制药100%股权
罗欣药业(002793)11月8日股东户数2.79万户，较上期减少1.59%
证券之星 · 11-14
罗欣药业(002793)11月8日股东户数2.79万户，较上期减少1.59%
罗欣药业（002793）11月13日主力资金净卖出1235.71万元
证券之星 · 11-13
罗欣药业（002793）11月13日主力资金净卖出1235.71万元
罗欣药业(002793)10月31日股东户数2.84万户，较上期增加8.03%
证券之星 · 11-06
罗欣药业(002793)10月31日股东户数2.84万户，较上期增加8.03%
罗欣药业（002793）10月30日主力资金净卖出1355.56万元
证券之星 · 10-30
罗欣药业（002793）10月30日主力资金净卖出1355.56万元
罗欣药业（002793）10月25日主力资金净卖出2577.14万元
证券之星 · 10-25
罗欣药业（002793）10月25日主力资金净卖出2577.14万元
罗欣药业（002793）10月22日主力资金净卖出3659.67万元
证券之星 · 10-22
罗欣药业（002793）10月22日主力资金净卖出3659.67万元
罗欣药业最新公告：替戈拉生片新适应症获得药品注册证书
证券之星 · 10-21
罗欣药业最新公告：替戈拉生片新适应症获得药品注册证书
罗欣药业(002793.SZ)：替戈拉生片新适应症获得药品注册证书
智通财经 · 10-21
罗欣药业(002793.SZ)：替戈拉生片新适应症获得药品注册证书
10月17日罗欣药业发生1笔大宗交易 成交金额1999.93万元
证券之星 · 10-17
10月17日罗欣药业发生1笔大宗交易 成交金额1999.93万元
10月16日罗欣药业涨停分析：中药，新冠病毒防治，医药概念热股
证券之星 · 10-16
10月16日罗欣药业涨停分析：中药，新冠病毒防治，医药概念热股
异动快报：罗欣药业（002793）10月16日13点1分触及涨停板
证券之星 · 10-16
异动快报：罗欣药业（002793）10月16日13点1分触及涨停板
罗欣药业（002793）10月10日主力资金净买入611.48万元
证券之星 · 10-10
罗欣药业（002793）10月10日主力资金净买入611.48万元
罗欣药业(002793)9月30日股东户数2.62万户，较上期减少1.57%
证券之星 · 10-09
罗欣药业(002793)9月30日股东户数2.62万户，较上期减少1.57%
罗欣药业(002793.SZ)：颜锦霞将持股1.02亿股 成为持股5%以上股东
智通财经 · 10-08
罗欣药业(002793.SZ)：颜锦霞将持股1.02亿股 成为持股5%以上股东
罗欣药业最新公告：股东拟协议转让公司股份1.02亿股
证券之星 · 10-08
罗欣药业最新公告：股东拟协议转让公司股份1.02亿股
罗欣药业(002793.SZ)拟推2024年员工持股计划
智通财经 · 09-27
罗欣药业(002793.SZ)拟推2024年员工持股计划
罗欣药业（002793）9月26日主力资金净卖出860.49万元
证券之星 · 09-26
罗欣药业（002793）9月26日主力资金净卖出860.49万元
罗欣药业（002793）9月25日主力资金净卖出141.25万元
证券之星 · 09-25
罗欣药业（002793）9月25日主力资金净卖出141.25万元
加载更多
公司概况
公司名称：
罗欣药业集团股份有限公司
所属行业：
医药制造业
上市日期：
2016-04-15
主营业务：
罗欣药业集团股份有限公司是集生产、科研于一体的设计制造企业。重大资产重组实施后，主营业务变更为医药产品的研发、生产和销售。公司产品主要有消化系统药品、抗生素类药品及呼吸系统药品、药品及医疗器械的物流配送。
发行价格：
11.97
{"stockData":{"symbol":"002793","market":"SZ","secType":"STK","nameCN":"罗欣药业","latestPrice":4.19,"timestamp":1731991131000,"preClose":4.14,"halted":0,"volume":6859221,"delay":0,"floatShares":1086000000,"shares":1088000000,"eps":-0.6409,"marketStatus":"午间休市","marketStatusCode":3,"change":0.05,"latestTime":"11-19 11:30:00","open":4.16,"high":4.25,"low":4.15,"amount":28805900,"amplitude":0.0242,"askPrice":4.2,"askSize":217,"bidPrice":4.19,"bidSize":233,"shortable":0,"etf":0,"ttmEps":-0.6409,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1731992400000},"adr":0,"adjPreClose":4.14,"symbolType":"stock","openAndCloseTimeList":[[1731979800000,1731987000000],[1731992400000,1731999600000]],"highLimit":4.55,"lowLimit":3.73,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1087588486,"pbRate":2.14,"roa":"--","roe":"--","epsLYR":-0.61,"committee":0.28835,"marketValue":4557000000,"floatMarketCap":4550000000,"peRate":-6.537681,"changeRate":0.0121,"turnoverRate":0.0063,"status":0},"requestUrl":"/m/hq/s/002793","defaultTab":"news","newsList":[{"id":"2484345624","title":"罗欣药业最新公告：控股子公司山东罗欣拟公开挂牌出售乐康制药100%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2484345624","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484345624?lang=zh_cn&edition=full","pubTime":"2024-11-18 20:40","pubTimestamp":1731933615,"startTime":"0","endTime":"0","summary":"罗欣药业公告，公司控股子公司山东罗欣拟通过临沂产权交易中心以公开挂牌方式出售其全资子公司乐康制药100%股权，挂牌价为1.9亿元。本次交易完成后，山东罗欣不再持有乐康制药股权，乐康制药将不再纳入公司合并报表范围。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111800030151.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","01477","08058","BK0201","BK1574","BK0132","002793","BK1191","BK0239"],"gpt_icon":0},{"id":"2484628949","title":"盘活资产 罗欣药业(002793.SZ)控股子公司拟公开挂牌出售乐康制药100%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2484628949","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484628949?lang=zh_cn&edition=full","pubTime":"2024-11-18 19:13","pubTimestamp":1731928390,"startTime":"0","endTime":"0","summary":"智通财经APP讯，罗欣药业(002793.SZ)公告，公司控股子公司山东罗欣药业集团股份有限公司(简称“山东罗欣”)拟通过公开挂牌方式出售其全资子公司山东罗欣乐康制药有限公司(简称“乐康制药”)100%股权，确定挂牌价为1.9亿元。本次交易完成后，公司控股子公司山东罗欣不再持有乐康制药股权，乐康制药将不再纳入公司合并报表的范围。公告称，本次交易有利于公司盘活资产，优化公司资源配置，增强公司的盈利能力和抗风险能力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1212440.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0001","BK0132","BK1574","BK0239","BK0201","BK1191","01477","002793","08058"],"gpt_icon":0},{"id":"2483082857","title":"罗欣药业(002793)11月8日股东户数2.79万户，较上期减少1.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483082857","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483082857?lang=zh_cn&edition=full","pubTime":"2024-11-14 17:01","pubTimestamp":1731574907,"startTime":"0","endTime":"0","summary":"证券之星消息，近日罗欣药业披露，截至2024年11月8日公司股东户数为2.79万户，较10月31日减少452.0户，减幅为1.59%。在化学制药行业个股中，罗欣药业股东户数低于行业平均水平，截至11月8日，化学制药行业平均股东户数为3.1万户。从股价来看，2024年10月31日至2024年11月8日，罗欣药业区间涨幅为1.74%，在此期间股东户数减少452.0户，减幅为1.59%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111400028418.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0239","BK0001","002793","BK0201","08058"],"gpt_icon":0},{"id":"2483102591","title":"罗欣药业（002793）11月13日主力资金净卖出1235.71万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483102591","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483102591?lang=zh_cn&edition=full","pubTime":"2024-11-13 15:28","pubTimestamp":1731482901,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年11月13日收盘，罗欣药业报收于4.54元，下跌2.78%，换手率1.75%，成交量18.96万手，成交额8671.37万元。11月13日的资金流向数据方面，主力资金净流出1235.71万元，占总成交额14.25%，游资资金净流入271.27万元，占总成交额3.13%，散户资金净流入964.44万元，占总成交额11.12%。罗欣药业主营业务：医药产品的研发、生产和销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111300019836.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","BK0132","08058","BK0201","002793","BK0239"],"gpt_icon":0},{"id":"2481624376","title":"罗欣药业(002793)10月31日股东户数2.84万户，较上期增加8.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481624376","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481624376?lang=zh_cn&edition=full","pubTime":"2024-11-06 17:02","pubTimestamp":1730883752,"startTime":"0","endTime":"0","summary":"证券之星消息，近日罗欣药业披露，截至2024年10月31日公司股东户数为2.84万户，较10月10日增加2109.0户，增幅为8.03%。在化学制药行业个股中，罗欣药业股东户数低于行业平均水平，截至10月31日，化学制药行业平均股东户数为3.1万户。从股价来看，2024年10月10日至2024年10月31日，罗欣药业区间涨幅为5.99%，在此期间股东户数增加2109.0户，增幅为8.03%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110600029812.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","BK0201","BK0132","BK0239","BK0001","002793"],"gpt_icon":0},{"id":"2479722811","title":"罗欣药业（002793）10月30日主力资金净卖出1355.56万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479722811","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479722811?lang=zh_cn&edition=full","pubTime":"2024-10-30 15:24","pubTimestamp":1730273062,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年10月30日收盘，罗欣药业报收于4.6元，下跌4.17%，换手率3.09%，成交量33.59万手，成交额1.55亿元。10月30日的资金流向数据方面，主力资金净流出1355.56万元，占总成交额8.75%，游资资金净流出25.35万元，占总成交额0.16%，散户资金净流入1380.9万元，占总成交额8.92%。罗欣药业主营业务：医药产品的研发、生产和销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000022015.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002793","BK0201","08058","BK0132","BK0001"],"gpt_icon":0},{"id":"2478768646","title":"罗欣药业（002793）10月25日主力资金净卖出2577.14万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478768646","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478768646?lang=zh_cn&edition=full","pubTime":"2024-10-25 15:22","pubTimestamp":1729840952,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年10月25日收盘，罗欣药业报收于4.67元，下跌0.64%，换手率2.79%，成交量30.33万手，成交额1.43亿元。10月25日的资金流向数据方面，主力资金净流出2577.14万元，占总成交额18.05%，游资资金净流出0.83万元，占总成交额0.01%，散户资金净流入2577.97万元，占总成交额18.06%。罗欣药业主营业务：医药产品的研发、生产和销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500020121.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0201","BK0239","08058","BK0001","002793"],"gpt_icon":0},{"id":"2477180307","title":"罗欣药业（002793）10月22日主力资金净卖出3659.67万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477180307","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477180307?lang=zh_cn&edition=full","pubTime":"2024-10-22 15:26","pubTimestamp":1729581985,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年10月22日收盘，罗欣药业报收于4.75元，下跌2.86%，换手率4.02%，成交量43.64万手，成交额2.13亿元。10月22日的资金流向数据方面，主力资金净流出3659.67万元，占总成交额17.2%，游资资金净流入814.57万元，占总成交额3.83%，散户资金净流入2845.1万元，占总成交额13.37%。罗欣药业主营业务：医药产品的研发、生产和销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102200018354.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","BK0239","BK0132","BK0001","08058","002793"],"gpt_icon":0},{"id":"2477183544","title":"罗欣药业最新公告：替戈拉生片新适应症获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2477183544","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477183544?lang=zh_cn&edition=full","pubTime":"2024-10-21 16:53","pubTimestamp":1729500784,"startTime":"0","endTime":"0","summary":"罗欣药业公告，公司下属子公司山东罗欣药业集团股份有限公司收到国家药品监督管理局核准签发的适应症为“与适当的抗生素联用以根除幽门螺杆菌”的替戈拉生片《药品注册证书》。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102100020260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","08058","BK0201","BK0239","BK0001","BK0132"],"gpt_icon":0},{"id":"2477326833","title":"罗欣药业(002793.SZ)：替戈拉生片新适应症获得药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2477326833","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477326833?lang=zh_cn&edition=full","pubTime":"2024-10-21 16:27","pubTimestamp":1729499236,"startTime":"0","endTime":"0","summary":"智通财经APP讯，罗欣药业 发布公告，近日，公司下属子公司山东罗欣药业集团股份有限公司收到国家药品监督管理局核准签发的适应症为“与适当的抗生素联用以根除幽门螺杆菌”的替戈拉生片《药品注册证书》。P-CAB与抗生素联合用药，通过其抑酸作用，为抗生素根除幽门螺杆菌提供最佳pH环境。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1196708.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["08058","BK0201","BK0132","BK0239","BK0001","002793"],"gpt_icon":0},{"id":"2476197496","title":"10月17日罗欣药业发生1笔大宗交易 成交金额1999.93万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476197496","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476197496?lang=zh_cn&edition=full","pubTime":"2024-10-17 16:40","pubTimestamp":1729154444,"startTime":"0","endTime":"0","summary":"证券之星消息，10月17日罗欣药业发生大宗交易，交易数据如下：大宗交易成交价格4.3元，相对当日收盘价折价4.66%，成交465.1万股，成交金额1999.93万元，买方营业部为中国银河证券股份有限公司北京知春路证券营业部，卖方营业部为东北证券股份有限公司杭州教工路证券营业部。近三个月该股共发生3笔大宗交易，合计成交9.67万手，折价成交2笔。截至2024年10月17日收盘，罗欣药业报收于4.51元，下跌2.59%，换手率4.62%，成交量50.14万手，成交额2.28亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101700024233.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","BK0201","BK0239","08058","002793","BK0132"],"gpt_icon":0},{"id":"2475933914","title":"10月16日罗欣药业涨停分析：中药，新冠病毒防治，医药概念热股","url":"https://stock-news.laohu8.com/highlight/detail?id=2475933914","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475933914?lang=zh_cn&edition=full","pubTime":"2024-10-16 15:38","pubTimestamp":1729064318,"startTime":"0","endTime":"0","summary":"证券之星消息，罗欣药业10月16日涨停收盘，收盘价4.63元。该股于13点1分涨停，未打开涨停，截止收盘封单资金为8529.53万元，占其流通市值1.7%。10月16日的资金流向数据方面，主力资金净流入1740.84万元，占总成交额10.13%，游资资金净流出1166.45万元，占总成交额6.79%，散户资金净流出574.39万元，占总成交额3.34%。近5日资金流向一览见下表：该股为中药，新冠病毒防治，医药概念热股，当日中药概念上涨0.45%，新冠病毒防治概念上涨0.3%，医药概念上涨0.26%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101600020356.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","BK0201","BK0239","08058","002793","BK0001","BK1161","BK1574","09939","BK1515","159938"],"gpt_icon":0},{"id":"2475360946","title":"异动快报：罗欣药业（002793）10月16日13点1分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2475360946","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475360946?lang=zh_cn&edition=full","pubTime":"2024-10-16 13:08","pubTimestamp":1729055331,"startTime":"0","endTime":"0","summary":"证券之星10月16日盘中消息，13点1分罗欣药业触及涨停板。目前价格4.63，上涨9.98%。10月16日的资金流向数据方面，主力资金净流出371.19万元，占总成交额3.26%，游资资金净流出170.81万元，占总成交额1.5%，散户资金净流入542.0万元，占总成交额4.76%。近5日资金流向一览见下表：罗欣药业主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101600017266.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0201","08058","BK0132","BK0001","BK0239","002793"],"gpt_icon":0},{"id":"2474762169","title":"罗欣药业（002793）10月10日主力资金净买入611.48万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474762169","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474762169?lang=zh_cn&edition=full","pubTime":"2024-10-10 15:21","pubTimestamp":1728544914,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年10月10日收盘，罗欣药业报收于4.34元，下跌4.62%，换手率3.41%，成交量37.05万手，成交额1.63亿元。10月10日的资金流向数据方面，主力资金净流入611.48万元，占总成交额3.75%，游资资金净流入2178.91万元，占总成交额13.36%，散户资金净流出2790.4万元，占总成交额17.11%。罗欣药业主营业务：医药产品的研发、生产和销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101000020828.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002793","BK0132","BK0201","BK0239","BK0001","08058"],"gpt_icon":0},{"id":"2474217643","title":"罗欣药业(002793)9月30日股东户数2.62万户，较上期减少1.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474217643","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474217643?lang=zh_cn&edition=full","pubTime":"2024-10-09 18:14","pubTimestamp":1728468884,"startTime":"0","endTime":"0","summary":"证券之星消息，近日罗欣药业披露，截至2024年9月30日公司股东户数为2.62万户，较9月20日减少418.0户，减幅为1.57%。在化学制药行业个股中，罗欣药业股东户数低于行业平均水平，截至9月30日，化学制药行业平均股东户数为3.21万户。从股价来看，2024年9月20日至2024年9月30日，罗欣药业区间涨幅为28.24%，在此期间股东户数减少418.0户，减幅为1.57%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100900033349.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0132","002793","08058","BK0001","BK0201"],"gpt_icon":0},{"id":"2473476147","title":"罗欣药业(002793.SZ)：颜锦霞将持股1.02亿股 成为持股5%以上股东","url":"https://stock-news.laohu8.com/highlight/detail?id=2473476147","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473476147?lang=zh_cn&edition=full","pubTime":"2024-10-08 22:24","pubTimestamp":1728397482,"startTime":"0","endTime":"0","summary":"协议转让后，得怡成都、得怡恒佳、得怡欣华将不再持有公司股份，得怡健康、得盛健康合计持有公司股份1064.0378万股，占公司总股本比例0.98%，前述股东将不再是公司合计持股5%以上股东;颜锦霞女士持有公司股份1.02亿股，占公司总股本比例9.42%，成为公司持股5%以上股东。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1191396.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0132","002793","BK0239","08058","BK0201","BK0001"],"gpt_icon":0},{"id":"2473173476","title":"罗欣药业最新公告：股东拟协议转让公司股份1.02亿股","url":"https://stock-news.laohu8.com/highlight/detail?id=2473173476","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473173476?lang=zh_cn&edition=full","pubTime":"2024-10-08 22:20","pubTimestamp":1728397235,"startTime":"0","endTime":"0","summary":"罗欣药业公告，公司合计持股5%以上股东得怡成都、得怡恒佳、得怡欣华与颜锦霞签署《股份转让协议》，得怡成都拟向颜锦霞转让其持有的无限售流通股4169.23万股；得怡恒佳拟向颜锦霞转让其持有的无限售流通股3578.98万股；得怡欣华拟向颜锦霞转让其持有的无限售流通股2496.14万股。本次协议转让后，得怡成都、得怡恒佳、得怡欣华将不再持有公司股份，颜锦霞将持有公司股份1.02亿股，占公司总股本比例9.42%，成为公司持股5%以上股东。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024100800038973.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["08058","BK0239","002793","BK0001","BK0201","BK0132"],"gpt_icon":0},{"id":"2470704677","title":"罗欣药业(002793.SZ)拟推2024年员工持股计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2470704677","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470704677?lang=zh_cn&edition=full","pubTime":"2024-09-27 19:40","pubTimestamp":1727437235,"startTime":"0","endTime":"0","summary":"智通财经APP讯，罗欣药业(002793.SZ)发布2024年员工持股计划(草案)，持股计划股票来源为公司回购专用账户回购的罗欣药业A股普通股股票。持股计划拟持有的标的股票数量不超过2602.7861万股，约占员工持股计划草案公布日公司股本总额的2.39%。员工持股计划购买回购股份的价格(不含预留部分)为2.03元/股。此次员工持股计划存续期不超过60个月，首次授予部分标的股票分三期解锁，锁定期分别为12个月、24个月、36个月，均自公司公告首次授予部分标的股票过户至本员工持股计划名下之日起计算。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1188394.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0001","BK0201","BK0239","08058","002793","BK0132"],"gpt_icon":0},{"id":"2470420849","title":"罗欣药业（002793）9月26日主力资金净卖出860.49万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470420849","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470420849?lang=zh_cn&edition=full","pubTime":"2024-09-26 15:24","pubTimestamp":1727335464,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年9月26日收盘，罗欣药业报收于3.93元，上涨0.26%，换手率2.0%，成交量21.67万手，成交额8375.59万元。9月26日的资金流向数据方面，主力资金净流出860.49万元，占总成交额10.27%，游资资金净流入1.03万元，占总成交额0.01%，散户资金净流入859.46万元，占总成交额10.26%。罗欣药业主营业务：医药产品的研发、生产和销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092600017219.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0132","002793","BK0239","08058","BK0201","BK0001"],"gpt_icon":0},{"id":"2470286749","title":"罗欣药业（002793）9月25日主力资金净卖出141.25万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470286749","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470286749?lang=zh_cn&edition=full","pubTime":"2024-09-25 15:17","pubTimestamp":1727248652,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2024年9月25日收盘，罗欣药业报收于3.92元，上涨5.38%，换手率2.62%，成交量28.47万手，成交额1.12亿元。9月25日的资金流向数据方面，主力资金净流出141.25万元，占总成交额1.26%，游资资金净流入168.76万元，占总成交额1.51%，散户资金净流出27.51万元，占总成交额0.25%。罗欣药业主营业务：医药产品的研发、生产和销售。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024092500018171.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0001","BK0201","BK0239","08058","002793","BK0132"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2016-04-15","address":"山东省临沂市罗庄区罗七路18号4号楼","stockEarnings":[{"period":"1week","weight":-0.1154},{"period":"1month","weight":-0.0961},{"period":"3month","weight":0.0534},{"period":"6month","weight":-0.1568},{"period":"1year","weight":-0.3019},{"period":"ytd","weight":-0.2276}],"companyName":"罗欣药业集团股份有限公司","boardCode":"AI0027","perCapita":"38893股","boardName":"医药制造业","registeredCapital":"108758万元","compareEarnings":[{"period":"1week","weight":-0.0421},{"period":"1month","weight":0.0191},{"period":"3month","weight":0.1595},{"period":"6month","weight":0.0523},{"period":"1year","weight":0.0882},{"period":"ytd","weight":0.1173}],"survey":" 罗欣药业集团股份有限公司是集生产、科研于一体的设计制造企业。重大资产重组实施后，主营业务变更为医药产品的研发、生产和销售。公司产品主要有消化系统药品、抗生素类药品及呼吸系统药品、药品及医疗器械的物流配送。","serverTime":1731991177410,"listedPrice":11.97,"stockholders":"27921人(较上一季度减少1.59%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"罗欣药业(002793)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供罗欣药业(002793)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"罗欣药业,002793,罗欣药业股票,罗欣药业股票老虎,罗欣药业股票老虎国际,罗欣药业行情,罗欣药业股票行情,罗欣药业股价,罗欣药业股市,罗欣药业股票价格,罗欣药业股票交易,罗欣药业股票购买,罗欣药业股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"罗欣药业(002793)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供罗欣药业(002793)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}